Indian Medicines exposition in London

for Ministry of Health and Family Welfare | Date - 12-05-2006


An official team of experts is to make a presentation on Ayurveda to the European Medicines Agency in London on Monday. The aim is to present evidence relating to the scientific basis of Ayurveda and the potential it holds for global health care. This presentation is being done under the aegis of India-European Union Joint Working Group on Pharmaceuticals and Bio-technology. The Experts team is being led by Shri Shiv Basant, Joint Secretary, Department of Ayush. The other members are Dr. S.K. Sharma, Adviser (Ay.), Dr. G.N. Qazi, Director, Regional Research Laboratory, CSIR, Jammu, Dr. Arvind Chopra, Centre for Rheumatic Diseases, Pune, Shri C.K. Katiar, Director, Herbal Division, Ranbaxy .
>
The Department of Ayurveda, Yoga & Naturopathy, Unani, Sidha and Homeopathy (Ayush) is also organizing an exposition of Indian medicines during the World Health Assembly in Geneva from 24-26 May, 2006. This is to show-case the scientific basis of Ayush systems of medicine and the Research and Development work done on medicinal plants, plant extracts and medicines. The premier manufacturers of Ayurveda, Yunani and Sidha drugs and medicinal plant extract manufacturers like Dabur India, Himalaya Drugs, Baidyanath, Zandu Pharmaceuticals, Hamdard, Sami Labs, Maharishi Ayurveda and Health resort managers like Suokya, Bangalore and Kerala Tourism are participating in this exposition. The Minister for Health & Family Welfare, Dr. Anbumani Ramadoss will inaugurate the Exposition of Indian Medicines. A high level delegation led by Secretary, Ayush will represent the Department of Ayush in this Exposition.
>
The virtual demonstration of therapeutic techniques like Panchkarma, Ksar-Sutra etc, lectures, presentations and interactive sessions will also take place during the event. In addition, display of natural health products, scientific and regulatory documents and short films on Ayurveda and Yoga have also been arranged.
>
PVR/NT
(Release ID :17636)

(This is an archive of the press release and has not been edited by our staff.)